Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy

免疫疗法 医学 癌症研究 无容量 免疫系统 免疫检查点 膀胱癌 免疫学 肿瘤微环境 髓样 癌症 内科学
作者
Marice Alcantara,Wilson S. Tang,Dongfang Wang,Damian Kaniowski,Elaine Kang,Nazlı Dizman,Alex Chehrazi‐Raffle,Luís Meza,Zeynep Büşra Zengin,Jérémy Hall,Joann Hsu,Colt A. Egelston,Dayson Moreira,Alan Horsager,Sumanta K. Pal,Marcin Kortylewski
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:14: 1274781-1274781 被引量:14
标识
DOI:10.3389/fimmu.2023.1274781
摘要

Introduction Immune checkpoint blockade (ICB) improved clinical outcomes in renal and bladder cancer patients, but the response rates remain limited especially in metastatic disease. While STAT3 transcription factor is well-known master regulator of tumor immune evasion, little is known about the role of STAT3 in the resistance of renal or bladder cancers to immunotherapy. Methods To better understand immune alterations associated with ICB resistance, we assessed blood biomarkers in renal cancer patients classified as responders or non-responders to first line nivolumab/ipilimumab immunotherapy. Results We observed that non-responders showed elevated levels of proinflammatory mediators, such as IL-1RA, IL-6, IL-8 and to lesser extent IL-10, which are associated with STAT3 activation and tumor immunosuppression. In addition, we found STAT3 activation primarily in circulating myeloid immune cells such as tolerogenic MDSCs. To assess whether STAT3 inhibition within these cell subsets can promote antitumor immune responses and/or enhance sensitivity to ICB in vivo , we used an original antisense oligonucleotide (ASO) strategy for myeloid-cell selective STAT3 knockdown (CpG-STAT3ASO). Our results in syngeneic models of renal and bladder cancers in mice demonstrated potent antitumor activity of CpG-STAT3ASO alone in contrast to PD1 blockade alone in both models. The CpG-STAT3ASO/anti-PD1 combination improved therapeutic efficacy especially against bladder tumors. Therapeutic efficacy correlated with activation of dendritic cells (DCs) and M1 macrophages in the tumor microenvironment, reduced percentages of regulatory T cells (Tregs) and the expansion of CD8 T cells in both tumor models. Discussion/Conclusion Our study underscores the potential of using myeloid-cell targeted CpG-STAT3 inhibitors for genitourinary cancer therapy to disrupt tolerogenic signaling, restore immune cell activity and sensitivity to immune checkpoint inhibitors and/or T cell-based immunotherapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CAOHOU的应助被电生理搬运工采纳,获得10
刚刚
cyx完成签到 ,获得积分10
1秒前
欣慰的嘉熙完成签到,获得积分10
1秒前
熊逍完成签到 ,获得积分10
2秒前
Maestro_S的应助被DW采纳,获得10
2秒前
2秒前
wangfei发布了新的文献求助30
3秒前
3秒前
畅快的柠檬完成签到 ,获得积分10
3秒前
3秒前
4秒前
wzy小号完成签到 ,获得积分10
4秒前
科研通AI6.3的应助被TreKex采纳,获得10
4秒前
5秒前
AAA发布了新的文献求助10
6秒前
热情灵珊发布了新的文献求助10
7秒前
研友_Z7XO48发布了新的文献求助10
8秒前
josh完成签到,获得积分10
8秒前
cyx关注了科研通微信公众号
8秒前
YANG发布了新的文献求助10
9秒前
9秒前
wang发布了新的文献求助10
10秒前
10秒前
英吉利25发布了新的文献求助10
11秒前
搜集达人的应助被123采纳,获得10
11秒前
12秒前
12秒前
Owen的应助被华夫饼采纳,获得10
12秒前
柔弱熊猫完成签到 ,获得积分10
12秒前
13秒前
大气幻柏发布了新的文献求助10
13秒前
平生发布了新的文献求助10
13秒前
wanci的应助被DW采纳,获得10
14秒前
充电宝的应助被庾傀斗采纳,获得10
14秒前
14秒前
15秒前
高A完成签到,获得积分10
15秒前
科研通AI2S的应助被yzb采纳,获得10
15秒前
第一作者发布了新的文献求助10
16秒前
周澍完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188249
求助须知:如何正确求助?哪些是违规求助? 9576071
关于积分的说明 21845183
捐赠科研通 7786256
什么是DOI,文献DOI怎么找? 3435261
关于科研通互助平台的介绍 2559559
邀请新用户注册赠送积分活动 2482169